The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
- Conditions
- Idiopathic Short Stature
- Interventions
- Drug: Inpegsomatropin Injection
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT06927310
- Locations
- 🇨🇳
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Capital Institute of Pediatrics, Beijing (SHOUER), Beijing, Beijing, China
🇨🇳Children's Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06924385
- Locations
- 🇨🇳
Peking University Third Hospital, Beijin, Beijing, China
Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT06893796
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants
- Conditions
- Non-alcoholic Steatohepatitis
- Interventions
- Drug: ACT500 tabletsDrug: Placebo
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT06716905
- Locations
- 🇨🇳
Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 350
- Registration Number
- NCT06707922
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
- Conditions
- Essential Thrombocythemia
- Interventions
- Drug: Peginterferon α-2b injection
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT06552429
- Locations
- 🇨🇳
Henan Cancer Hospital, Henan, China
🇨🇳Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
A Trial of YPEG-rhGH in Children With Short Stature
- Conditions
- Idiopathic Short StatureSmall for Gestational AgeTurner Syndrome
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 78
- Registration Number
- NCT05838885
- Locations
- 🇨🇳
The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳The Second Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04885647
- Locations
- 🇨🇳
The First Affiliated Hospital Of Baotou Medical college,Inner Mongolia University Of Science and Technology, Hohhot, Inner Mongol, China
🇨🇳The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
🇨🇳The Second Affiliated Hospital Of Chongqing Medical University, Chongqing, Chongqing, China
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 475
- Registration Number
- NCT04846491
- Locations
- 🇨🇳
The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
🇨🇳Traditional Chinese Medicine hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
🇨🇳The First Hospital of Shanxi Medical University, Taiyuan, China
Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
- Conditions
- Growth Hormone Deficiency
- Interventions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Target Recruit Count
- 434
- Registration Number
- NCT04513171
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China